ArticleBiomedical engineering and computational biology2025
Hybrid Deep Learning for Brain Tumor Detection: Combining DenseNet and Custom CNN for Enhanced Accuracy.
Article in Biomedical engineering and computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Deep learning in brain tumor detection has become an important breakthrough in medical imaging to facilitate a fast and accurate diagnosis. Conventional models such as VGG, SVM, and common CNNs are competitive, yet fail to provide the sensitivity and specificity needed in real-time diagnosis purposes. Objectives: The objective of the proposed study is to generate a hybrid deep learning architecture of the DenseNet and a self-developed Convolutional Neural Network (CNN) in order to increase the classification accuracy, sensitivity, and specificity of a brain tumor detection medical image. Design: A Hybrid architecture consisting of DenseNet feature reuse and connectivity with a domain-specific custom CNN is suggested to retrieve high-level semantic and fine-grained features. The design focuses on performance evaluation with respect to the state-of-the-art models and ensemble frameworks. Methods: The brain tumor data set was preprocessed, and the augmentation methods, such as translation and rotation, were applied. A training and testing subsets of the dataset were formed. The hybrid approach, formed by DenseNet layers and a self-created CNN model, was implemented and tested. The performance of the model was contrasted with that of other benchmark classifiers such as SVM and VGG, DenseNet (single), CNN ensembles, and Hybrid Ensembles. Results: The hybrid DenseNet-Custom CNN model was more accurate and had better classification results than the standard models. In particular, it surpassed the accuracy of SVM (96%), VGG (94%), DenseNet (92%), and Hybrid Ensemble models (~95.2%), while the FPS remained equivalent to SVM and substantially lower than VGG. It proved better sensitivity and specificity with better feature representation and interpretation, as it made more accurate tumor classification. Conclusion: Incorporating DenseNet with a custom CNN model can increase the capabilities of brain tumor detection in medical imaging. This hybrid performance can use both general-purpose deep learning and domain-specific feature engineering, and it provides a practical suggestion of the approach that involves a satisfactory solution in the diagnostic sense. It verifies that the combination of more than 2 methods is productive in enhancing the results of medical image classification activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.